|
Recommended
|
June 23 - 26
San Diego
________________
|
|
Cut the Cost of Shipping Services
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on FedEx Shipments
Click here to learn more
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
| The List |
Los Angeles Ranked Among Top 10 Biopharma
Regions in the US
 With companies such as Medtronic Diabetes (Northridge), Boston Scientific Neuromodulation (Valencia), Edwards Lifesciences (Irvine), Abbott Medical Optics (Santa Ana), Biosense Webste (Irwindale)r, St Jude Cardiac Rhythm Management Division (Sylmar), etc., the Geater Los Angeles region is well known as one of the top 5 medical device hubs in the US. By contrast, a few would think about the region as one of the top biopharma clusters. But when the editors of Genetic Engineering News (GEN) looked at biopharma assets and stockholders in Greater Los Angeles, they found enough to warrant placing Los Angeles among the top ten biopharma clusters in the US and ahead of Chicago, the home of Baxter International and AbbVie ... Click here to access the list
|
| Business Incentives |
Santa Clarita Announces a New Business Incentives Program to Attract High-Tech and Bioscience Companies to North Los Angeles County
 The San Fernando Valley Business Journal reported that "the Santa Clarita Economic Development Corp., in partnership with Los Angeles County, has set aside $200,000 for Industry Cluster Attraction Incentives. The aim is to attract new businesses to targeted industries: aerospace, medical devices, information technology, manufacturing and entertainment" .... Read more
|
|
Coming May 15
| |
SoCalBio Workshop on
Accessing Government Grant Funding
May 15, 2014, 8:00 am to 4:00 pm
@ Calit2 Auditorium, UCI (Irvine)
Your one-stop shop for information about new NIH and DoD non-dilutive grant funding opportunities for biosciencce companies and how to access them.
|
|
Make Your Voice Heard in DC
|
Join SoCalBio at the BIO Legislative Day in Washington, D.C. on April 8 and 9
Join SoCalBio's team and other biotechnology executives from across the country who will go to D.C. for a day and a half of legislative briefings and advocacy on Capitol Hill. This fly-in is organized by the Biotechnology Industry Organization to give you the opportunity to meet with your congressional representative and other legislators to educate them about the importance of the biotech industry for job and wealth creation.
Contact SoCalBio, if you are a bioscience industry executive interested in participation and located in Los Angeles, Orange County, the Inland Empire and the communities of the Gold Coast of Ventura and Santa Barbara. Send email to: scbc@socalbio.org
|
| Meet New SoCalBio Members |
ADRx (Thousand Oaks)
ADRx, Inc. is a biopharmaceutical company created to develop first-in-class and best-in-class drugs for amyloid diseases. The company intends to discover and develop drug candidates independently and in partnertnership with pharmaceutical and biotechnology companies ...
Biotechnical Services Inc. (San Diego)
Provides scientific lab equipment sales and services, such as calibration and validation.... Learn more
Response Genetics (Los Angeles)
Response Genetics is a publicly traded biotech company focused on developing molecular diagnostic assays to help determine the patient's response to cancer therapies ... Learn More
Pharmacos Biopharmaceutical Services (Irvine)
Pharmacos services small to mid-size specialty biopharmaceutical and medical device companies by providing a complete suite of outsourcing and/or consulting services which support drug development, registration, commercialization, life cycle management and commercial operations ..
CRB USA (Carlsbad)
CRB is a global design, construction and consulting firm that services the bioscience and other advanced technology industries. The firm employs over 600 people in 10 offices serving clients throughout the world ... Learn More
|
|
Recommended Event
| |
Celebrate Medical Innovation at LA BioMed
Thursday, April 24, 2014 from -- 12:30 PM to 5:30 PM
Free for SoCalBio Members
|
|
Drug Coverage
|
White House Withdraws Plan Allowing Limits to Medicare Coverage for Some Drugs
SoCalBio joined many bioscience industry organizations and patient advocacy groups around the country in opposition to this plan
The New York Times reports that "Under pressure from patients, pharmaceutical companies and members of Congress from both parties, the Obama administration on Monday withdrew a proposal that would have allowed insurers to limit Medicare coverage for certain classes of drugs, including those used to treat depression and schizophrenia... Read more
|
|
Med Device Tax
|
Medical Device Tax: At Least $510 Million Paid in 2013
A MassDevice.com reported that 14 companies accounted for more than 97% of the nearly $500 million collected in med device tax. "The financial impact of the medical device tax appears to be much lower than originally feared, a MassDevice.com analysis shows, with the medtech industry paying at least $500 million on the 2.3% levy last year" ... Read more
|
| Digital Health |
 Medgadget.com noticed "an increasing number of physicians turning to entrepreneurship to effect change in the health care system." One of these is Dr. Kourosh Parsapour, Assistant Professor at UCI's School of Medicine, who has co-founded personalRN to improve patient education and reduce readmissions. Read interview with Dr. Parsapour about personalRN
|
|
Molecular Diagnostics
|
Los Angeles-Based Response Genetics, Inc. to Offer Expanded KRAS Mutation Test to Improve Treatment Decisions for Colorectal Cancer Patients
"As a company known for its first-to-market innovation, we are pleased to introduce a test that detects more mutations in a gene not examined previously, allowing for a more thorough and comprehensive screening of colorectal cancer," said Thomas A. Bologna, Chairman and Chief Executive Officer of Response Genetics. "Identifying a broader range of KRAS mutations increases the potential for more targeted and appropriate treatment of colorectal cancer patients" ... Read more
|
|
Aesthetic Medicine
|
Calabasas-Based KYTHERA Biopharmaceuticals Acquires Rights to ATX-101 Outside of the US and Canada from Bayer Consumer Care
"We are very pleased to acquire all rights to ATX-101 outside the U.S. and Canada, giving us full global rights to develop and commercialize ATX-101," said Keith Leonard, KYTHERA's president and CEO. "We appreciate Bayer's investment in the ATX-101 global development program over the past four years. During that time we strengthened our financial position and assembled a senior executive team with global aesthetic development and commercialization expertise. I am confident in our ability to maximize the long-term global value of ATX-101. While our primary focus remains filing our U.S. New Drug Application in the second quarter of 2014, we also plan to make multiple ex-U.S. regulatory submissions in the next 12 months."
|
| Jobs ... Jobs ... jobs |
Second Sight Medical Products (Sylmar)
Bruin Biometrics (Los Angeles)
Chromologic (Pasadena)
- Senior Hardware Engineer - Machine Vision Systems
- Sr. Scientist - Optics
- Sr. Scientist - Biomedical Engineering
- Senior Applications Engineer
- Senior Applications Engineer - Biomedical
- Principal Research Scientist - Biologics
Gilead (San Dimas)
Gilead (Oceanside)
Biolase (Irvine)
Xencor (Monrovia)
Aubery Group (Irvine)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
